PHAT icon

Phathom Pharmaceuticals
PHAT

Overview Fund Activity

110 hedge funds and large institutions have $453M invested in Phathom Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 48 increasing their positions, 24 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
110
Holders Change
+7
Holders Change %
+6.8%
% of All Funds
1.75%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.06%
New
15
Increased
48
Reduced
24
Closed
7
Calls
$1.62M
Puts
$326K
Net Calls
+$1.29M
Net Calls Change
-$4.25M

Top Buyers

1
BlackRock
1
BlackRock
New York
$25.3M
2
Citadel Advisors
2
Citadel Advisors
Florida
$2.86M
3
GGHC
3
Gilder Gagnon Howe & Co
New York
$13.6M
4
GTC
4
Ghost Tree Capital
New York
$4.1M
5
Jacobs Levy Equity Management
5
Jacobs Levy Equity Management
New Jersey
$2.91M

Top Sellers

1
DM
1
Deerfield Management
New York
$0
2
TCM
2
Tang Capital Management
California
$0
3
APM
3
Avidity Partners Management
Texas
$16.8M
4
SCM
4
Silverarc Capital Management
Massachusetts
$0
5
6CM
5
683 Capital Management
New York
$11.4M
Name Holding Trade Value Shares
Change 		Shares
Change %
Northern Trust
26
Northern Trust
Illinois
$2.79M +$535K +51,590 +24%
Charles Schwab
27
Charles Schwab
California
$2.56M +$703K +67,811 +38%
SAM
28
Simplify Asset Management
Nevada
$2.47M – – –
ACM
29
Altium Capital Management
New York
$2.28M +$130K +12,568 +6%
AA
30
AlphaCentric Advisors
Puerto Rico
$1.66M +$311K +30,000 +23%
JPMorgan Chase & Co
31
JPMorgan Chase & Co
New York
$1.5M +$112K +10,760 +8%
Millennium Management
32
Millennium Management
New York
$1.45M +$1.16M +111,407 +399%
Goldman Sachs
33
Goldman Sachs
New York
$1.44M -$168K -16,168 -10%
D.E. Shaw & Co
34
D.E. Shaw & Co
New York
$1.35M +$175K +16,871 +15%
GCP
35
GSA Capital Partners
United Kingdom
$1.26M +$705K +67,983 +126%
UOC
36
UBS O'Connor
Illinois
$1.22M -$239K -23,000 -16%
Wellington Management Group
37
Wellington Management Group
Massachusetts
$1.04M +$18.6K +1,797 +2%
Bank of New York Mellon
38
Bank of New York Mellon
New York
$986K +$171K +16,478 +21%
AG
39
Algert Global
California
$952K +$952K +91,820 New
Walleye Capital
40
Walleye Capital
New York
$885K +$885K +85,372 New
Two Sigma Investments
41
Two Sigma Investments
New York
$872K +$441K +42,563 +103%
State of Wisconsin Investment Board
42
State of Wisconsin Investment Board
Wisconsin
$869K -$26.3K -2,539 -3%
Federated Hermes
43
Federated Hermes
Pennsylvania
$852K -$848K -81,808 -50%
MCM
44
Moore Capital Management
New York
$830K +$207K +20,000 +33%
Morgan Stanley
45
Morgan Stanley
New York
$811K +$60.8K +5,862 +8%
Jane Street
46
Jane Street
New York
$734K +$618K +59,584 +532%
PMAM
47
Penn Mutual Asset Management
Pennsylvania
$651K – – –
Swiss National Bank
48
Swiss National Bank
Switzerland
$624K -$117K -11,300 -16%
TI
49
Trexquant Investment
Connecticut
$610K +$420K +40,524 +221%
RhumbLine Advisers
50
RhumbLine Advisers
Massachusetts
$586K +$65.7K +6,332 +13%
1
2
3 4 5